Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sonoma Pharmaceuticals (SNOA) Cash & Equivalents: 2011-2012

Historic Cash & Equivalents for Sonoma Pharmaceuticals (SNOA) over the last 2 years, with Mar 2012 value amounting to $3.4 million.

  • Sonoma Pharmaceuticals' Cash & Equivalents rose 33.00% to $6.6 million in Q4 2012 from the same period last year, while for Dec 2012 it was $6.6 million, marking a year-over-year increase of 33.00%. This contributed to the annual value of $3.4 million for FY2012, which is 23.34% down from last year.
  • As of FY2012, Sonoma Pharmaceuticals' Cash & Equivalents stood at $3.4 million, which was down 23.34% from $4.4 million recorded in FY2011.
  • In the past 5 years, Sonoma Pharmaceuticals' Cash & Equivalents registered a high of $4.4 million during FY2011, and its lowest value of $3.4 million during FY2012.
  • For the 2-year period, Sonoma Pharmaceuticals' Cash & Equivalents averaged around $3.9 million, with its median value being $3.9 million (2011).
  • Data for Sonoma Pharmaceuticals' Cash & Equivalents shows a maximum YoY declined of 23.34% (in 2012) over the last 5 years.
  • Sonoma Pharmaceuticals' Cash & Equivalents (Yearly) stood at $4.4 million in 2011, then decreased by 23.34% to $3.4 million in 2012.